NIH VideoCast - A new day for drug development in neuroscience

Skip Navigation

A new day for drug development in neuroscience

Loading... Loading video...

519 Views

Air date:	Wednesday, June 24, 2015, 3:00:00 PM Time displayed is Eastern Time, Washington DC Local
Views:	Total views: 519 (168 Live, 351 On-demand)
Category:	WALS - Wednesday Afternoon Lectures
Runtime:	01:12:18
Closed captioning:	Check box to display CC outside of the video Note: You can drag the captioning window around and resize it
Description:	Wednesday Afternoon Lecture Series (WALS) Dr. Dolmetsch's group is responsible for leveraging advances in human genetics to model and treat neuropsychiatric and neurodegenerative diseases. Areas of focus include genomics, induced pluripotent stem cells, and brain circuitry. Dr. Dolmetsch joined Novartis in August 2013 from the Stanford University School of Medicine, where he was an associate professor of neurobiology. He was also the senior director of Molecular Networks at the Allen Institute for Brain Research. He studied the molecular roots of autism and other neurodevelopmental disorders, including the role of calcium-channel signaling. His laboratory recently used induced pluripotent stem cells to develop an in vitro model of Timothy syndrome, a rare disease with a variety of symptoms, including the characteristic features of autism. For more information go to https://oir.nih.gov/wals

NLM Title:	A new day for drug development in neuroscience / Ricardo Dolmetsch.
Author:	Dolmetsch, Ricardo E. National Institutes of Health (U.S.),
Publisher:
Abstract:	(CIT): Wednesday Afternoon Lecture Series (WALS) Dr. Dolmetsch's group is responsible for leveraging advances in human genetics to model and treat neuropsychiatric and neurodegenerative diseases. Areas of focus include genomics, induced pluripotent stem cells, and brain circuitry. Dr. Dolmetsch joined Novartis in August 2013 from the Stanford University School of Medicine, where he was an associate professor of neurobiology. He was also the senior director of Molecular Networks at the Allen Institute for Brain Research. He studied the molecular roots of autism and other neurodevelopmental disorders, including the role of calcium-channel signaling. His laboratory recently used induced pluripotent stem cells to develop an in vitro model of Timothy syndrome, a rare disease with a variety of symptoms, including the characteristic features of autism.
Subjects:	Drug Delivery Systems Drug Discovery Mental Disorders--drug therapy Neurodegenerative Diseases--drug therapy
Publication Types:	Lecture Webcast

NLM Classification:	WM 402
NLM ID:	101665638
CIT Live ID:	16428
Permanent link:	https://videocast.nih.gov/watch=16428

Related Videos...